Literature DB >> 2202744

Antibiotics in periodontal therapy: advantages and disadvantages.

J Slots1, T E Rams.   

Abstract

Antibiotic treatment of periodontitis aims at eradicating or controlling specific pathogens. Prime candidates for antibiotic therapy are patients with recently diagnosed active periodontitis or a history of recurrent disease who fail to stabilize following mechanical/surgical therapy. Since a variety of microbes with differing antimicrobial susceptibility profiles may cause periodontitis, selection of antimicrobial agents should be based on proper microbial diagnosis and sensitivity testing, as well as consideration of the patient's medical status. The risk of treating chemotherapeutically solely on the basis of clinical features, radiographic findings or a limited microbiological analysis, is failure to control the pathogens or overgrowth of new pathogens. A review of published papers reveals that appropriate systemic antibiotic therapy may enhance healing in patients with recent or high risk of periodontal breakdown. Systemic antibiotic therapy seems more predictable than topical administration in eradicating periodontal pathogens from deep periodontal pockets. Several promising antimicrobial agents for periodontitis treatment need testing in placebo-controlled, double-blind, randomized clinical trials.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2202744     DOI: 10.1111/j.1365-2710.1992.tb01220.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  57 in total

1.  Antibiotic resistance in bacteria isolated from subgingival plaque in a norwegian population with refractory marginal periodontitis.

Authors:  Trude Handal; Dominique A Caugant; Ingar Olsen
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

2.  Stability study of tetracyclines with respect to their use in slow release systems.

Authors:  V C Honnorat-Benabbou; A A Lebugle; B Sallek; D Duffaut-Lagarrigue
Journal:  J Mater Sci Mater Med       Date:  2001-02       Impact factor: 3.896

3.  In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations.

Authors:  M J Pavicić; A J van Winkelhoff; J de Graaff
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

4.  Synergistic effects between amoxicillin, metronidazole, and the hydroxymetabolite of metronidazole against Actinobacillus actinomycetemcomitans.

Authors:  M J Pavicić; A J van Winkelhoff; J de Graaff
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

5.  The effect of locally delivered doxycycline as an adjunctive therapy to scaling and root planing in smokers.

Authors:  Hassan Al Hulami; Nadir Babay; Fatin Awartani; Sukumaran Anil
Journal:  Saudi Dent J       Date:  2011-05-03

6.  Adjunctive effect of antimicrobial photodynamic therapy in induced periodontal disease. Animal study with histomorphometrical, immunohistochemical, and cytokine evaluation.

Authors:  Paula Gabriela Faciola Pessôa de Oliveira; Adriana Maria Mariano Silveira E Souza; Arthur Belém Novaes; Mário Taba; Michel Reis Messora; Daniela Bazan Palioto; Márcio Fernando Moraes Grisi; Antônio Cláudio Tedesco; Sérgio Luis Scombatti de Souza
Journal:  Lasers Med Sci       Date:  2016-06-28       Impact factor: 3.161

7.  In Vivo Antibacterial Efficacy of Nitric Oxide-Releasing Hyperbranched Polymers against Porphyromonas gingivalis.

Authors:  Lei Yang; Li Jing; Yizu Jiao; Lufei Wang; Julie T Marchesan; Steven Offenbacher; Mark H Schoenfisch
Journal:  Mol Pharm       Date:  2019-07-30       Impact factor: 4.939

8.  A new bioerodible polymer insert for the controlled release of metronidazole.

Authors:  K A Gates; H Grad; P Birek; P I Lee
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

9.  Susceptibilities of Eikenella corrodens, Prevotella intermedia, and Prevotella nigrescens clinical isolates to amoxicillin and tetracycline.

Authors:  N Luong; J Tsai; C Chen
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

10.  Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain.

Authors:  M T Andrés; W O Chung; M C Roberts; J F Fierro
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.